A randomized controlled trial of narrowband ultraviolet B vs bath-psoralen plus ultraviolet A photochemotherapy for psoriasis

R. S. Dawe, H. Cameron, S. Yule, I. Man, N. J. Wainwright, S. H. Ibbotson, J. Ferguson

    Research output: Contribution to journalArticle

    60 Citations (Scopus)

    Abstract

    In 1991, consensus guidelines recommended psoralen plus ultraviolet A photochemotherapy (PUVA) for those requiring second-line therapy for psoriasis. Narrowband (TL-01) UVB has since become more widely available, replacing the less effective broadband sources. Objectives To compare the efficacy of TL-01 UVB phototherapy and trimethoxypsoralen (TMP) bath-PUVA for chronic plaque psoriasis.
    Original languageEnglish
    Pages (from-to)1194-1204
    Number of pages11
    JournalThe British journal of dermatology
    Volume148
    Issue number6
    DOIs
    Publication statusPublished - 2003

    Keywords

    • Ultraviolet Rays
    • Patient Satisfaction
    • Humans
    • Aged
    • PUVA Therapy
    • Photosensitizing Agents
    • Ficusin
    • Psoriasis
    • Balneology
    • Adult
    • Treatment Outcome
    • Follow-Up Studies
    • Middle Aged
    • Female
    • Male

    Fingerprint Dive into the research topics of 'A randomized controlled trial of narrowband ultraviolet B vs bath-psoralen plus ultraviolet A photochemotherapy for psoriasis'. Together they form a unique fingerprint.

  • Cite this